Eltek Reports Q2 2026 Results: Key Test for Capacity Ramp and Margin Recovery

What happened

Eltek Ltd. announced its second-quarter 2026 financial results on August 18, 2026, covering the quarter ended June 30, 2026. This report was eagerly awaited because it provides the first post-deadline evidence on whether the company completed its accelerated $15 million investment program by Q2 2026 and achieved operational milestones such as coating-line commissioning. In the prior DeepValue master report, ELTK was rated WAIT due to uncertain margin recovery and FX volatility, with a specific checkpoint requiring gross margin ≥20% and coating-line progress by this quarter. The press release headline alone does not disclose whether revenue, gross margin, or profitability met expectations, leaving investors to rely on the full filing for details. Given the stock's sensitivity to execution and FX, the market reaction will depend on whether the results confirm stabilization of yields and throughput, or reveal continued drag from ramp-up costs.

Implication

If the Q2 2026 report shows gross margin at or above 20% and confirms coating-line commissioning on schedule, the WAIT thesis could be revised upward, with a re-assessment window shortened. Conversely, if gross margin remains below 15% or the company discloses further delays in the coating line, the bear scenario gains credibility, and the stock may retest the $8.00 attractive entry level. FX exposure remains a wildcard; any repeat of the $1.0M-scale financial expense impacts seen in 2025 would undermine margin recovery even if operations improve. Defense mix stability near 60%+ is also essential to absorb higher fixed costs from the capacity expansion, so investors should monitor revenue concentration disclosures. Until these details emerge, maintaining a cautious stance with a trim above $11.00 and attractive entry near $8.00 remains prudent.

Thesis delta

The release of Q2 2026 results is a necessary but not sufficient condition to alter the current WAIT thesis. Without disclosed figures, there is no confirmed shift in the investment thesis; the same execution and FX criteria remain the key drivers. A thesis change will require clear evidence of coating-line commissioning and gross margin recovery to at least 20%.